Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History SRRK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics SRRK

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Scholar Rock Holding Corp

SRRK
Current price
35.48 USD -0.27 USD (-0.76%)
Last closed 35.99 USD
ISIN US80706P1030
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 417 092 352 USD
Yield for 12 month +350.83 %
1Y
3Y
5Y
10Y
15Y
SRRK
21.11.2021 - 28.11.2021

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts. Address: 301 Binney Street, Cambridge, MA, United States, 02142

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

49.67 USD

P/E Ratio

Dividend Yield

Financials SRRK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures SRRK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-2 844 000 USD

Current Quarter

Last Quarter

EBITDA -268 992 992 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -50.15 %
PEG Ratio
Return On Equity TTM -106.71 %
Wall Street Target Price 49.67 USD
Revenue TTM
Book Value 3.29 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100.00 %
Dividend Yield
Gross Profit TTM -190 134 000 USD
Earnings per share -2.55 USD
Diluted Eps TTM -2.55 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation SRRK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 8.22
Price Sales TTM 13.14
Enterprise Value EBITDA -2.08
Price Book MRQ 10.81

Technical Indicators SRRK

For 52 Weeks

6.76 USD 46.98 USD
50 Day MA 32.36 USD
Shares Short Prior Month 14 232 577
200 Day MA 32.69 USD
Short Ratio 13.90
Shares Short 14 932 097
Short Percent 27.81 %